ResultsIQ › Latest results › Park Medi World Limited
Park Medi World Limited Q4 FY26 results press release summary
NSE: PARKHOSPS · BSE: 544645
Results press release of 12 May 2026, summarised by AI from the filing.
Immediate priorities are integration of acquired assets, improving utilisation across newer facilities, and sustaining profitability.
Key takeaways
- Priorities Immediate priorities are integration of acquired assets, improving utilisation across newer facilities, and sustaining profitability.
Park Medi World Limited Q1 FY27 results
As filed: Revenue ₹476 cr, EBITDA ₹126 cr, PAT ₹88.6 cr, EBITDA margin 26.5%.
Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹476 cr). Scored once a year-earlier consolidated quarter exists.
Earlier results and the share price after them
- Q4 FY26: Revenue ₹460 cr, EBITDA ₹127 cr, PAT ₹76.8 cr, EBITDA margin 27.7%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹460 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +5.2% in 30 days (Nifty 500: −3.0%).
- Q3 FY26: Revenue ₹410 cr, EBITDA ₹99.4 cr, PAT ₹52.9 cr, EBITDA margin 24.3%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹410 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +29.5% in 30 days (Nifty 500: +1.5%).
Past price moves after results do not indicate future moves. Not a recommendation.
Park Medi World Limited earnings call, investor presentation and press release summaries
Figures from the company's filings with NSE and BSE. Not investment advice.